![Hagit Marchaim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hagit Marchaim worked as Senior Vice President-Regulatory Affairs at Alcobra Ltd. Prior to that, she was Vice President-Regulatory Affairs at CureTech Ltd. from 2011 to 2013.
From 2009 to 2011, she was Head-Affairs Department at Omrix Biopharmaceuticals Ltd. Marchaim received her undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.
She also holds an MBA from The College of Management Academic Studies.
| Companies | Position | End |
|---|---|---|
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Corporate Officer/Principal | 01/01/2013 |
Omrix Biopharmaceuticals Ltd.
 Omrix Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2011 |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary pharmaceutical products | General Counsel | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary pharmaceutical products | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CureTech Ltd.
CureTech Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
The College of Management Academic Studies
 The College of Management Academic Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Omrix Biopharmaceuticals Ltd.
Omrix Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
